Navigation Links
Nektar Presents Positive Proof-of-Concept Clinical Data for Its New Opioid Molecule, NKTR-181, at American Academy of Pain Medicine's 28th Annual Meeting
Date:2/27/2012

that have issued may not be enforceable, or additional intellectual property licenses from third parties may be required; and (vii) the outcome of any existing or future intellectual property or other litigation related to our proprietary drug candidates.  Other important risks and uncertainties are detailed in our reports and other filings with the Securities and Exchange Commission ("SEC"), including without limitation, those risks and uncertainties set forth in Nektar's Form 10-Q for the quarter ended September 30, 2011, filed with the SEC on November 4, 2011 and our Form 8-K filed with the SEC on January 11, 2012. We undertake no obligation to update any forward-looking statement, whether written or oral, that may be made from time to time, whether as a result of new information, future developments or otherwise.

Nektar Investor Inquiries:
Jennifer Ruddock/Nektar Therapeutics                        (415)482-5585
Susan Noonan/SA Noonan Communications, LLC   (212) 966-3650

Nektar Media Inquiries:  
Karen Bergman/BCC Partners                                   (650) 575-1509
Michelle Corral/BCC Partners                                     (415) 794-8662

(1) Lalovic et al., Clinical Pharmacology and Therapeutics, 2006.

(2) 2011 National Academy of Sciences. Relieving Pain in America: A Blueprint for Transforming Prevention, Care, Education and Research, 2010 Deci
'/>"/>

SOURCE Nektar Therapeutics
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10

Related medicine technology :

1. Nektar to Announce Financial Results for the Fourth Quarter and Year-End of 2011 on Wednesday, February 29, 2012, After Close of U.S.-Based Financial Markets
2. Positive Data for Nektars New Mu-Opioid Analgesic Molecule to Treat Acute Pain Highlighted at Neuroscience 2011
3. Nektar Therapeutics Reports Third Quarter 2011 Financial Results
4. Nektar to Announce Financial Results for the Third Quarter of 2011 on Wednesday, November 2, 2011, After Close of U.S.-Based Financial Markets
5. Nektar Therapeutics President and CEO, Howard W. Robin, to Present at the UBS 2011 Global Life Sciences Conference in New York City
6. Nektar Initiates Second Phase 1 Clinical Study Evaluating NKTR-181, A Novel Opioid Molecule, for Treatment of Chronic Pain
7. Nektar Therapeutics Reports Second Quarter 2011 Financial Results
8. Nektar to Announce Financial Results for the Second Quarter of 2011 on Thursday, August 4, 2011, After Close of U.S.-Based Financial Markets
9. Nektar Therapeutics President and CEO Howard W. Robin to Present at the Jefferies 2011 Global Healthcare Conference in New York
10. Nektar Announces New Phase 2 Data for NKTR-102 to Be Presented at 2011 ASCO Annual Meeting
11. FDA Grants Orphan Drug Designation for Nektars Investigational Drug, NKTR-102, for Treatment of Women with Ovarian Cancer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/27/2015)... , Aug. 27, 2015 ieCrowd™ ... in the commercial development of the company,s supplemental ... Smart Oxygen device, being developed by ieCrowd,s subsidiary ... a patient,s changing demand for oxygen based on ... 510 (k) submission for the Smart Oxygen device ...
(Date:8/27/2015)... Pa. , Aug. 27, 2015  Now that ... the Da Vinci S™ surgical robot, hospitals with robotic ... plans. They also need to see where they stand ... on the right patients? Have they adopted best practices ... surgery program in the future? ECRI Institute, ...
(Date:8/27/2015)... MARIETTA, Ga. , Aug. 27, 2015  MiMedx ... regenerative medicine company utilizing human amniotic tissue and ... and therapies for the Wound Care, Surgical, Orthopedic, ... healthcare, responded today and corrected the multiple inaccuracies ... Transplant Foundation ("MTF") regarding the recent rulings from ...
Breaking Medicine Technology:Smart Oxygen Solutions' Supplemental Oxygen Delivery Device Achieves FDA Regulatory Pathway Milestone 2Smart Oxygen Solutions' Supplemental Oxygen Delivery Device Achieves FDA Regulatory Pathway Milestone 3Smart Oxygen Solutions' Supplemental Oxygen Delivery Device Achieves FDA Regulatory Pathway Milestone 4ECRI Institute's New Robotic Surgery Service Helps Hospitals Brace for Change 2ECRI Institute's New Robotic Surgery Service Helps Hospitals Brace for Change 3MiMedx Corrects Inaccuracies In MTF Press Release Regarding The Recent Rulings From The Patent Trial And Appeal Board 2MiMedx Corrects Inaccuracies In MTF Press Release Regarding The Recent Rulings From The Patent Trial And Appeal Board 3MiMedx Corrects Inaccuracies In MTF Press Release Regarding The Recent Rulings From The Patent Trial And Appeal Board 4
... Lasers, a global developer, manufacturer and provider of laser, ... applications, announced today that it will launch a nationwide ... Breast Cancer Awareness Month.  The Declare Your Freedom program ... month of October 2011. Radiation therapists ...
... Oct. 5, 2011 Hill-Rom Holdings, Inc. (NYSE: ... and 2012 financial guidance on Wednesday, October 26, 2011.  You ... on Thursday, October 27, 2011, at 8 a.m. ET. ... Earnings and 2012 Financial Guidance release will be issued to ...
Cached Medicine Technology:In Honor of National Breast Cancer Awareness Month, Alma Lasers Launches Nationwide Radiation Tattoo Removal Program, Declare Your Freedom 2Hill-Rom Holdings, Inc. Invites You to Join Its Fiscal 2011 Fourth Quarter Earnings and 2012 Financial Guidance Webcast 2
(Date:8/29/2015)... ... August 29, 2015 , ... Targeted ... and improve the lives of patients, according to a newly published report. Surviving ... read the full article. , The authors of the new paper focus ...
(Date:8/29/2015)... ... 2015 , ... Brands like Toppik , Eau Thermale Avene and Bliss ... a threshold of $49.00 was required to qualify for free standard shipping,” said Jennifer ... shipping for customers regardless of the item’s selling price.” , With competitive pricing in ...
(Date:8/29/2015)... ... , ... ProDrop Particles includes over 40 particle backdrops designed for use in ... that users can shrink and stretch in the Final Cut Pro X timeline. Choose ... brightness, scale, speed, range, and flare attributes with intuitive controls found in the top-right ...
(Date:8/29/2015)... ... August 29, 2015 , ... ... localized area with stretching, soft tissue manipulation. Platelet rich plasma injections also have ... through research to improve treatment outcomes. This localized treatment seems to address ...
(Date:8/29/2015)... TX (PRWEB) , ... August 29, 2015 , ... ... allows the company to freely market and sell Arterosil and Arterosil HP, and ... Health Sciences, LLC (DHS) sued Vascular Health Sciences, LLC (VHS) in the United ...
Breaking Medicine News(10 mins):Health News:Top Mesothelioma Researchers Highlight Targeted Therapies in New Report, According to Surviving Mesothelioma 2Health News:TheBeautyPlace.com Discounts Shipping on Select Brands 2Health News:FCPX Effects Developer, Pixel Film Studios, Releases ProDrop Particles. 2Health News:NEW APPROACH for Treatment of Recurrent Hamstring Strains and Hamstring Tendinosis is Available for the First Time in NYC 2Health News:NEW APPROACH for Treatment of Recurrent Hamstring Strains and Hamstring Tendinosis is Available for the First Time in NYC 3
... women,s risk of recurrent or new tumors by more than ... -- There,s good news for the 60 percent of ... taking the aromatase inhibitor (AI) drug letrozole (Femara) can cut ... benefit was seen even when women initiated the drug one ...
... Johnson &,Johnson will participate in the Eleventh Annual ... at the Loews Miami Beach Hotel,in Miami, Florida. ... will represent the Company in a session scheduled ... be available to investors and other interested parties,by ...
... University School of Medicine and Children,s Healthcare of Atlanta ... to find new ways to make kidney transplants more ... partner with UCLA,s Mattel Childrens Hospital in Los Angeles ... Alto for a study of kidney transplants in children. ...
... Disease Control has awarded the Indiana University School of ... of nearly $10 million in funding over 5 years ... regional entities to share data and information to enhance ... disease outbreaks and other public health emergencies. , The ...
... Two Hospitals in Central Pennsylvania Earn Designation, ... Shield is,pleased to announce the recognition of Penn ... Blue Distinction Centers for Complex and Rare,Cancers., ... of new,cancer cases each year, making it difficult ...
... March 11 Granite State Manufacturing (GSM),a ... and,commercial markets, acquired Scandia Manufacturing Company Inc. ... mechanical marine systems,for the Department of Defense. ... the United States Navy., Granite State ...
Cached Medicine News:Health News:Late Use of Aromatase Inhibitor Still Effective Against Breast Cancer 2Health News:Late Use of Aromatase Inhibitor Still Effective Against Breast Cancer 3Health News:NIH grant to Emory and pediatric partners aims to improve kidney transplants for children 2Health News:Regenstrief Institute tapped by CDC to combat potentially catastrophic disease outbreaks 2Health News:Highmark Blue Shield and National Association Name Area Hospitals as Blue Distinction Centers for Complex and Rare Cancers 2Health News:Highmark Blue Shield and National Association Name Area Hospitals as Blue Distinction Centers for Complex and Rare Cancers 3Health News:Granite State Manufacturing Acquires Scandia Manufacturing Company Inc. 2
... 3D Signature is a state of ... that integrates blood, sterile body fluid ... powerful microbiology workstation with comprehensive capabilities. ... identification and where expanded flexibility in ...
The Vitek 2 is a fully automated bacteriology system that performs bacterial identification and susceptibility testing analysis using a standard inoculum. It detects resistance and helps combat bacte...
IDS Rapid ANA II System, a microbial identification system....
IDS Rapid SS/u, a microbial identification system....
Medicine Products: